UMC(UNIVERSITY MEDICAL CENTER)
61 N NELLIS BLVD, LAS VEGAS, NV 89110
NPI Number
1659311421
Practice location · View on Google Maps
SOS Verification: Pending Review
Multiple SOS Matches
Total Medicaid Payments
$7,094
-100% vs specialty average
Patients Seen
192
Total Claims
201
$ Per Patient
$37
Specialty avg: $313
Specialty Rank
#51 of 62
Clinic/Center providers in Nevada
Peer Average
$2,426,494
Average total for Clinic/Center
Claims per Patient
1.0
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2021 | $838 | |
| 2022 | $6,255 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique | 52 | $3,062 | 43.2% | $59 |
| 99203 | New patient office visit — moderate problem | 27 | $2,317 | 32.7% | $86 |
| 99213 | Office visit for a simple problem (established patient) | 31 | $1,714 | 24.2% | $55 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 39 | $0 | 0.0% | $0 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc | 52 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.